Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Schizophr Res. 2016 Jan 23;171(0):131–136. doi: 10.1016/j.schres.2016.01.021

Table 3.

Demographic, clinical, and cognitive differences between participants with intact versus impaired neurocognitive insight (n=168)

Intact Impaired
n Mean (sd) or % n Mean (sd) or % t or χ2 df p Cohen’s d
Age, years 77 43.6 (12.0) 91 41.9 (12.5) −0.91 166 0.364
Education, years 77 11.9 (1.9) 90 12.3 (2.2) 1.33 165 0.185
% Male 77 59.7 91 73.6 3.65 1 0.056
% Caucasian 77 48.1 91 53.8 0.80 2 0.671
% Hispanic ethnicity 77 16.9 91 25.3 1.74 1 0.187
% Schizophrenia 73 57.5 89 67.4 1.68 1 0.195
% Prescribed antipsychotic medication 76 97.4 88 98.9 0.51 1 0.476
% Living independently 77 77.9 91 68.1 4.43 3 0.219
% Employed 77 9.1 91 11.0 1.73 3 0.630
% Never married 70 47.1 75 53.3 7.53 6 0.275
WRAT-III reading total 77 43.2 (6.9) 89 44.6 (6.9) 1.26 164 0.210
Koren accuracy score 73 0.5 (0.2) 86 0.5 (0.2) −1.26 157 0.208 0.00
Mazes score 77 37.3 (7.9) 90 39.9 (8.2) 2.11 165 0.036 0.32
PANSS positive symptoms total 76 17.6 (5.7) 88 14.9 (5.5) −3.09 162 0.002 0.49
PANSS negative symptoms total 76 16.9 (6.3) 89 15.6 (6.3) −1.30 163 0.195 0.21
BDI-II total 76 20.3 (11.7) 88 10.4 (9.5) −5.87 144.08 <0.001 0.94
UPSA-B total 75 67.9 (13.9) 89 68.0 (16.5) 0.04 162 0.966 0.01

Note. Significant differences are indicated in bold font. BDI-II=Beck Depression Inventory, second edition; PANSS=Positive and Negative Syndrome Scale; UPSA-B=UCSD Performance Based Skills Assessment, Brief; WRAT-III=Wide Range Achievement Test, third edition